Abstract
Two compounds have recently been described which act as potent benzodiazepine (BDZ) antagonists in vivo and which, in vitro, show high affinity and selectivity for the BDZ receptor of the mammalian central nervous system (CNS). One, ethyl β-carboline-3-carboxylate (β-CCE), was extracted from human urine and may be related to an endogenous ligand for the BDZ receptor1–3. It reverses the effects of BDZs in vivo4,5 and in vitro6, but also has intrinsic activity, as it lowers the seizure threshold to drugs antagonistic to the action of γ-aminobutyric acid (GABA)5,7. The other compound, an imidazodiazepine (Ro 15-1788), which is also a potent and specific antagonist of BDZ binding in vivo and in vitro8, blocked the sedative, hypnotic and anticonvulsant actions of conventional BDZs, without demonstrating any intrinsic activity9,10. Because of the different profiles of action of these two BDZ ‘antagonists’, we have here investigated their interactions in two well established systems for assessing BDZ activity: seizure thresholds in vivo11 and the action of GABA on cervical sympathetic ganglia in vitro12. We find that Ro 15-1788 not only opposes the actions of BDZs but also is an effective antagonist of β-CCE in both systems. At high doses it has BDZ-like activity, suggesting that it may be a partial agonist at the BDZ receptor site.
Similar content being viewed by others
References
Braestrup, C., Nielsen, M. & Olsen, C. E. Proc. natn. Acad. Sci. U.S.A. 77, 2288–2292 (1980).
Nielsen, M. & Braestrup, C. Nature 286, 606–607 (1980).
Braestrup, C. & Nielsen, M. Trends pharmac. Sci. 1, 424–427 (1980).
Tenen, S. & Hirsch, J. D. Nature 288, 609–610 (1980).
Oakley, N. R. & Jones, B. J. Eur. J. Pharmac. 68, 381–382 (1980).
Mitchell, R. & Martin, I. Eur. J. Pharmac. 68, 513–514 (1980).
Cowen, P. J., Green, A. R., Nutt, D. J. & Martin, I. Nature 290, 54–55 (1981).
Möhler, A., Burkard, W. P., Keller, A. H., Richards, J. G. & Haefely, W. J. Neurochem. 37, 714–722 (1981).
Hunkeler, W. et al. Nature 290, 514–516 (1981).
Darrogh, A. et al. Lancet ii, 8–10 (1981).
Randall, L. O. & Kappell, B. in The Benzodiazepines (eds Garattini, S., Mussini, E. & Randall, L. O.) (Raven, New York, 1973).
Bowery, N. G. & Dray, A. Br. J. Pharmac. 63, 197–215 (1978).
Nutt, D. J., Cowen, P. J. & Green, A. R. Neuropharmacology 19, 1017–1023 (1980); Eur. J. Pharmac. 71, 287–295 (1981).
Costa, E., Guidotti, A., Mao, C. C. & Suria, A. Life Sci. 17, 167–176 (1975).
Olsen, R. W. J. Neurochem. 37, 1–13 (1981).
Kerwin, R. W., Olpe, H-R. & Schmutz, M. Br. J. Pharmac. 7, 545–551 (1980).
Lloyd, K. G. et al. Adv. Biochem. Pharmac 26, 199–206 (1981).
Adams, P. R. & Brown, D. A. J. Physiol., Lond. 250, 85–120 (1975).
Bowery, N. G. & Brown, D. A. Br. J. Pharmac. 50, 205–218 (1974).
Colquhoun, D. in Drug Receptors (ed. Rang, H. P.) 149–182 (Macmillan, London, 1975).
Ehlert, F. J., Roeske, W. R. & Yamamura, H. I. Life Sci. 29, 235–248 (1981).
Brown, D. A. & Marsh, S. J. Physiol., Lond. 246, 24–25P (1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nutt, D., Cowen, P. & Little, H. Unusual interactions of benzodiazepine receptor antagonists. Nature 295, 436–438 (1982). https://doi.org/10.1038/295436a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/295436a0
- Springer Nature Limited
This article is cited by
-
Differential behavioral effects of low efficacy positive GABAA modulators in combination with benzodiazepines and a neuroactive steroid in rhesus monkeys
British Journal of Pharmacology (2006)
-
Anti-conflict effects of benzodiazepines in rhesus monkeys: relationship with therapeutic doses in humans and role of GABAA receptors
Psychopharmacology (2006)
-
L-lysine is a barbiturate-like anticonvulsant and modulator of the benzodiazepine receptor
Neurochemical Research (1995)
-
Interactions of Ro15-4513, Ro15-1788 (flumazenil) and ethanol on measures of exploration and locomotion in rats
Psychopharmacology (1994)
-
Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain
Neurochemical Research (1993)